Correct me if I'm wrong but MDVN's drug was shown to be succesful true but only in the EXTENTION of patient survival. The use of CLSN's Tdox is an aid to accutally CURE the cancer. To me that is a major difference. If true would not / should not CLSN's drug be a lot more valuable and more desired than the one MDVN has?
News 
Market Data 
Discover 
AI
